195 related articles for article (PubMed ID: 37708024)
1. Multi-omics comparison of malignant and normal uveal melanocytes reveals molecular features of uveal melanoma.
Gentien D; Saberi-Ansari E; Servant N; Jolly A; de la Grange P; Némati F; Liot G; Saule S; Teissandier A; Bourc'his D; Girard E; Wong J; Masliah-Planchon J; Narmanli E; Liu Y; Torun E; Goulancourt R; Rodrigues M; Gaudé LV; Reyes C; Bazire M; Chenegros T; Henry E; Rapinat A; Bohec M; Baulande S; M'kacher R; Jeandidier E; Nicolas A; Ciriello G; Margueron R; Decaudin D; Cassoux N; Piperno-Neumann S; Stern MH; Gibcus JH; Dekker J; Heard E; Roman-Roman S; Waterfall JJ
Cell Rep; 2023 Sep; 42(9):113132. PubMed ID: 37708024
[TBL] [Abstract][Full Text] [Related]
2. Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines - A Pilot Study.
Herwig-Carl MC; Sharma A; Tischler V; Pelusi N; Loeffler KU; Holz FG; Zeschnigk M; Landreville S; Auw-Haedrich C; Noberini R; Bonaldi T
Invest Ophthalmol Vis Sci; 2024 Feb; 65(2):27. PubMed ID: 38349785
[TBL] [Abstract][Full Text] [Related]
3. PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Gezgin G; Luk SJ; Cao J; Dogrusöz M; van der Steen DM; Hagedoorn RS; Krijgsman D; van der Velden PA; Field MG; Luyten GPM; Szuhai K; Harbour JW; Jordanova ES; Heemskerk MHM; Jager MJ
JAMA Ophthalmol; 2017 Jun; 135(6):541-549. PubMed ID: 28448663
[TBL] [Abstract][Full Text] [Related]
4. Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort.
Lamas NJ; Lassalle S; Martel A; Nahon-Estève S; Macocco A; Zahaf K; Lalvee S; Fayada J; Lespinet-Fabre V; Bordone O; Pedeutour F; Baillif S; Hofman P
Pathology; 2023 Dec; 55(7):929-944. PubMed ID: 37863710
[TBL] [Abstract][Full Text] [Related]
5. PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma.
Field MG; Decatur CL; Kurtenbach S; Gezgin G; van der Velden PA; Jager MJ; Kozak KN; Harbour JW
Clin Cancer Res; 2016 Mar; 22(5):1234-42. PubMed ID: 26933176
[TBL] [Abstract][Full Text] [Related]
6. PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma.
Gelmi MC; Gezgin G; van der Velden PA; Luyten GPM; Luk SJ; Heemskerk MHM; Jager MJ
Invest Ophthalmol Vis Sci; 2023 Dec; 64(15):36. PubMed ID: 38149971
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of BAP1 and Preferentially Expressed Antigen in Melanoma (PRAME) Immunohistochemistry in Uveal Melanomas.
Han LM; Lee KW; Uludag G; Seider MI; Afshar AR; Bloomer MM; Pekmezci M
Mod Pathol; 2023 Apr; 36(4):100081. PubMed ID: 36788079
[TBL] [Abstract][Full Text] [Related]
8. Transposase mapping identifies the genomic targets of BAP1 in uveal melanoma.
Yen M; Qi Z; Chen X; Cooper JA; Mitra RD; Onken MD
BMC Med Genomics; 2018 Nov; 11(1):97. PubMed ID: 30400891
[TBL] [Abstract][Full Text] [Related]
9. GNA11 Q209L Mouse Model Reveals RasGRP3 as an Essential Signaling Node in Uveal Melanoma.
Moore AR; Ran L; Guan Y; Sher JJ; Hitchman TD; Zhang JQ; Hwang C; Walzak EG; Shoushtari AN; Monette S; Murali R; Wiesner T; Griewank KG; Chi P; Chen Y
Cell Rep; 2018 Feb; 22(9):2455-2468. PubMed ID: 29490280
[TBL] [Abstract][Full Text] [Related]
10. Relationship between clinical features, GEP class, and PRAME expression in uveal melanoma.
Schefler AC; Koca E; Bernicker EH; Correa ZM
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1541-1545. PubMed ID: 31065847
[TBL] [Abstract][Full Text] [Related]
11. EFS shows biallelic methylation in uveal melanoma with poor prognosis as well as tissue-specific methylation.
Neumann LC; Weinhäusel A; Thomas S; Horsthemke B; Lohmann DR; Zeschnigk M
BMC Cancer; 2011 Aug; 11():380. PubMed ID: 21871071
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of immunohistochemistry in concordance with mRNA analysis of PRAME in the stratification of high-risk uveal melanoma patients.
Kumar N; Singh MK; Singh L; Lomi N; Meel R; Pushker N; Sen S; Kashyap S
Hum Cell; 2023 Jan; 36(1):342-352. PubMed ID: 36282437
[TBL] [Abstract][Full Text] [Related]
13. Repression of genes involved in melanocyte differentiation in uveal melanoma.
Bergeron MA; Champagne S; Gaudreault M; Deschambeault A; Landreville S
Mol Vis; 2012; 18():1813-22. PubMed ID: 22815634
[TBL] [Abstract][Full Text] [Related]
14. A multi-omics deep learning model for hypoxia phenotype to predict tumor aggressiveness and prognosis in uveal melanoma for rationalized hypoxia-targeted therapy.
Zhao J; Yi Q; Li K; Chen L; Dai L; Feng J; Li Y; Zhou M; Sun J
Comput Struct Biotechnol J; 2022; 20():3182-3194. PubMed ID: 35782742
[TBL] [Abstract][Full Text] [Related]
15. SIRT2 Expression Is Higher in Uveal Melanoma than In Ocular Melanocytes.
Halfed DG; Zoroquiain P; Wood HA; Blanco P; Al-Saati N; Aldrees S; Bravo-Filho V; Burnier MN
Ocul Oncol Pathol; 2015 Dec; 2(2):100-4. PubMed ID: 27171429
[TBL] [Abstract][Full Text] [Related]
16. MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance.
Gelmi MC; Houtzagers LE; Strub T; Krossa I; Jager MJ
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682684
[TBL] [Abstract][Full Text] [Related]
17. Loss of macroH2A1 decreases mitochondrial metabolism and reduces the aggressiveness of uveal melanoma cells.
Giallongo S; Di Rosa M; Caltabiano R; Longhitano L; Reibaldi M; Distefano A; Lo Re O; Amorini AM; Puzzo L; Salvatorelli L; Palmucci S; Tibullo D; Russo A; Longo A; Lazzarino G; Li Volti G; Vinciguerra M
Aging (Albany NY); 2020 May; 12(10):9745-9760. PubMed ID: 32401230
[TBL] [Abstract][Full Text] [Related]
18. Uveal melanoma modeling in mice and zebrafish.
van den Bosch QCC; de Klein A; Verdijk RM; Kiliç E; Brosens E;
Biochim Biophys Acta Rev Cancer; 2024 Jan; 1879(1):189055. PubMed ID: 38104908
[TBL] [Abstract][Full Text] [Related]
19. Integrative Analysis Identifies Multi-Omics Signatures That Drive Molecular Classification of Uveal Melanoma.
Mo Q; Wan L; Schell MJ; Jim H; Tworoger SS; Peng G
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944787
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of chromosomal imbalances, gene mutations, and BAP1 expression in uveal melanoma.
Patrone S; Maric I; Rutigliani M; Lanza F; Puntoni M; Banelli B; Rancati S; Angelini G; Amaro A; Ligorio P; Defferrari C; Castagnetta M; Bandelloni R; Mosci C; DeCensi A; Romani M; Pfeffer U; Viaggi S; Coviello DA
Genes Chromosomes Cancer; 2018 Aug; 57(8):387-400. PubMed ID: 29689622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
